Fennec Pharmaceuticals Inc (FENC) insider trading
Every open-market stock purchase and sale by Fennec Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Robert Andrade (CFO) and 3 others sold $1.4M in the last 90 days.
- Last insider buy: Jeffrey S. Hackman (CEO), $97.6K, 16 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $12.6M (20 sales). Last close $10.62 on Sep 18, 2026.
Recent FENC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | Robert Andrade (CFO) | Bought (not open market) | — |
| Sep 30, 2026 | Jeffrey S. Hackman (CEO) | Bought (not open market) | — |
| Sep 30, 2026 | Terry L Evans (C-suite exec) | Bought (not open market) | — |
| Sep 30, 2026 | Pierre Sargis Sayad (C-suite exec) | Bought (not open market) | — |
| Sep 30, 2026 | Christiana Marie Cioffi (C-suite exec) | Bought (not open market) | — |
| Sep 15, 2026 | Marco Maria Brughera (Insider) | Sold | $160K |
| Sep 15, 2026 | Marco Maria Brughera (Insider) | Bought (not open market) | — |
| Sep 1, 2026 | Rosty Raykov (Insider) | Sold | $121K |
| Aug 31, 2026 | Pierre Sargis Sayad (C-suite exec) | Sold | $146K |
| Aug 31, 2026 | Rosty Raykov (Insider) | Bought (not open market) | — |
| Aug 31, 2026 | Christiana Marie Cioffi (C-suite exec) | Bought (not open market) | — |
| Aug 31, 2026 | Robert Andrade (CFO) | Bought (not open market) | — |
| Aug 31, 2026 | Terry L Evans (C-suite exec) | Bought (not open market) | — |
| Aug 31, 2026 | Jeffrey S. Hackman (CEO) | Bought (not open market) | — |
| Aug 31, 2026 | Pierre Sargis Sayad (C-suite exec) | Bought (not open market) | — |
| Aug 28, 2026 | Robert Andrade (CFO) | Bought (not open market) | — |
| Aug 27, 2026 | Robert Andrade (CFO) | Sold | $884K |
| Aug 3, 2026 | Rosty Raykov (Insider) | Sold | $95.8K |
| Jul 31, 2026 | Jeffrey S. Hackman (CEO) | Bought (not open market) | — |
| Jul 31, 2026 | Pierre Sargis Sayad (C-suite exec) | Bought (not open market) | — |
| Jul 31, 2026 | Christiana Marie Cioffi (C-suite exec) | Bought (not open market) | — |
| Jul 31, 2026 | Terry L Evans (C-suite exec) | Bought (not open market) | — |
| Jul 31, 2026 | Rosty Raykov (Insider) | Bought (not open market) | — |
| Jul 31, 2026 | Robert Andrade (CFO) | Bought (not open market) | — |
| Jun 30, 2026 | Jeffrey S. Hackman (CEO) | Bought (not open market) | — |
Who's trading FENC
- Pierre Sargis Sayad, C-suite exec: sold $146K (1 sale), last Sep 30, 2026
- Christiana Marie Cioffi, C-suite exec: other filings, last Sep 30, 2026
- Terry L Evans, C-suite exec: other filings, last Sep 30, 2026
- Jeffrey S. Hackman, CEO: other filings, last Sep 30, 2026
- Robert Andrade, CFO: sold $884K (1 sale), last Sep 30, 2026
- Marco Maria Brughera, Insider: sold $160K (1 sale), last Sep 15, 2026
- Rosty Raykov, Insider: sold $947K (11 sales), last Sep 1, 2026
- Chris A Rallis, Insider: sold $75.2K (2 sales), last Jun 10, 2026
- Jodi A Cook, Insider: other filings, last Jun 10, 2026
- Khalid Islam, Insider: other filings, last Jun 10, 2026
- Southpoint Capital Advisors LP, 10% owner: sold $10.3M (7 sales), last Dec 24, 2025
Get free alerts when an insider at Fennec Pharmaceuticals Inc files a new trade →